CDN STBBI Guidelines vs MDS Clear Path

Note: This application is intended for use by HEALTH PROFESSIONALS, and not the general public. For general information on sexually transmitted infections (STIs), refer to https://www.canada.ca/en/public-health/services/diseases.html This application provides Canadian health professionals with up-to-date recommendations for the screening, diagnosis, management, and treatment of STIs, including recommendations for antibiotic-resistant gonorrhea, in a convenient, concise, and easy to use format.
 It has been developed from the 2010 version of the Canadian Guidelines on Sexually Transmitted Infections (Guidelines) (http://www.phac-aspc.gc.ca/std-mts/sti-its/index-eng.php) and revised content from 2013 to 2016. These updates reflect emerging issues/trends affecting the management of STIs in Canada. Up-to-date information from other complementary resources has also been incorporated, including key recommendations from the HIV Screening and Testing Guide (2012) and the Management of Hepatitis B - Quick Reference (2013).
 The content is reflective of the most current evidence for the management of uncomplicated STIs in adults and youth only. It does not contain information for the management of STIs in pregnant women, children, neonates or complicated infections. 
 This application is intended to provide information to public health and clinical professionals and does not supersede any provincial/territorial legislative, regulatory, policy and practice requirements or professional guidelines that govern the practice of health professionals in their respective jurisdictions, whose recommendations may differ due to local epidemiology or context.

MDS Clear Path is designed to support healthcare professionals in the management of Myelodysplastic Syndromes (MDS), from diagnosis to treatment and best supportive care. It features a comprehensive treatment algorithm that is based upon clinical evidence and best practices in MDS management, and it is the outcome of Canada-wide physician consensus. MDS Clear Path includes extensive information on each therapy indicated for the treatment of MDS, from dosing and monitoring, to efficacy and safety data. It also contains supportive diagnostic tools, including links to pathology images, a WHO classification tool, and a unique prognostic calculator, which provides one-step calculations for the IPSS-R, IPSS, WPSS, and MPSS scoring systems. MDS Clear Path will ultimately support clinicians in the optimal management of their MDS patients by providing key tools, references, and recommendations within a user-friendly application. The content is specifically intended to be used by qualified physicians/medical professionals, to assist them in the management of MDS patients. The MDS Clear Path does not substitute, nor is it intended to substitute for the medical advice of an appropriately qualified and licensed physician or other healthcare provider. Use of the application is undertaken entirely on your own responsibility as a healthcare professional. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. If you are not a qualified physician/medical professional, please seek the advice of a qualified physician.